Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from OLBA HEALTHCARE HOLDINGS, Inc. ( (JP:2689) ).
OLBA HEALTHCARE HOLDINGS reported modest growth in consolidated net sales for the six months ended December 31, 2025, with revenue up 3.0% year on year to ¥62.4 billion, but profitability weakened as operating profit fell 16.6% to ¥673 million and profit attributable to owners of parent dropped 30.5% to ¥450 million. The company’s equity ratio edged down to 25.3% amid a slight increase in total assets, while earnings per share declined to ¥76.02, underscoring margin pressure despite top-line expansion. Management left its full-year forecast unchanged, projecting a 4.3% rise in net sales to ¥127.98 billion but anticipating only a 1.0% increase in operating profit and a 7.6% decline in full-year net profit, and it maintained guidance for an unaltered annual dividend of ¥80 per share, signaling a priority on stable shareholder returns even as earnings soften.
The most recent analyst rating on (JP:2689) stock is a Buy with a Yen2321.00 price target. To see the full list of analyst forecasts on OLBA HEALTHCARE HOLDINGS, Inc. stock, see the JP:2689 Stock Forecast page.
More about OLBA HEALTHCARE HOLDINGS, Inc.
OLBA HEALTHCARE HOLDINGS, Inc. is a Japan-based company listed on the Tokyo Stock Exchange that operates in the healthcare sector, providing medical- and care-related products and services. The group targets domestic healthcare institutions and related markets, positioning itself as a specialized supplier within Japan’s medical and nursing care value chain.
Average Trading Volume: 2,101
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen12.83B
For an in-depth examination of 2689 stock, go to TipRanks’ Overview page.